From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE

Key antigens of Leishmania species identified in the context of host responses in Leishmania-exposed individuals from disease-endemic areas were prioritized for the development of a subunit vaccine against visceral leishmaniasis (VL), the most deadly form of leishmaniasis. Two Leishmania proteins—nu...

Descripción completa

Detalles Bibliográficos
Autores principales: Coler, Rhea N, Duthie, Malcolm S, Hofmeyer, Kimberly A, Guderian, Jeffery, Jayashankar, Lakshmi, Vergara, Julie, Rolf, Tom, Misquith, Ayesha, Laurance, John D, Raman, Vanitha S, Bailor, H Remy, Cauwelaert, Natasha Dubois, Reed, Steven J, Vallur, Aarthy, Favila, Michelle, Orr, Mark T, Ashman, Jill, Ghosh, Prakash, Mondal, Dinesh, Reed, Steven G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488838/
https://www.ncbi.nlm.nih.gov/pubmed/26175894
http://dx.doi.org/10.1038/cti.2015.6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488838/
https://www.ncbi.nlm.nih.gov/pubmed/26175894
http://dx.doi.org/10.1038/cti.2015.6

Ejemplares similares